Asian Organization For Crohn'S And Colitis And Asia Pacific Association Of Gastroenterology Practice Recommendations For Medical Management And Monitoring Of Inflammatory Bowel Disease In Asia

Zhihua Ran,Kaichun Wu,Katsuyoshi Matsuoka,Yoon Tae Jeen,Shu Chen Wei,Vineet Ahuja,Minhu Chen,Pin Jin Hu,Akira Andoh,Hyo Jong Kim,Suk Kyun Yang,Mamoru Watanabe,Siew Chien Ng,Toshifumi Hibi,Ida Normiha Hilmi,Yasuo Suzuki,Dong Soo Han,Wai Keung Leung,Jose Sollano,Choon Jin Ooi,Jiaming Qian
DOI: https://doi.org/10.1111/jgh.15185
2021-01-01
Journal of Gastroenterology and Hepatology
Abstract:Inflammatory bowel disease (IBD) has increased in incidence and prevalence in Asian countries since the end of the 20th century. Moreover, differences in the cause, phenotypes, and natural history of IBD between the East and West have been recognized. Therefore, the Asian Organization for Crohn's and Colitis and the Asia Pacific Association of Gastroenterology have established recommendations on medical management of IBD in Asia. Initially, the committee members drafted 40 recommendations, which were then assessed according to Grading of Recommendations Assessment, Development and Evaluation. Eight statements were rejected as this indicated that consensus had not been reached. The recommendations encompass pretreatment evaluation; medical management of active IBD; medical management of IBD in remission; management of IBD during the periconception period and pregnancy; surveillance strategies for colitis-associated cancer; monitoring side effects of thiopurines and methotrexate; and infections in IBD.
What problem does this paper attempt to address?